aidot

[View original text]

On 29th of June, AI-based medical ICT company AIDOT (formerly Buzzpole) announced that it was finally selected as one of the 2020 'Seoul's Deal' to attract foreign investment, 

promoted jointly by the Seoul Metropolitan Government and the Invest Seoul Center. .

AIDOT developed the world's first artificial intelligence-based portable carotid ultrasound device and solution capable of pre-screening the risk of stroke, 

and received official approval for a multi-institutional multiclinical test (CRIS). The joint developer, Hallym University Chuncheon Sacred Heart Hospital, Department of Neurosurgery, 

Professor Jin-Pyeong Jeon, and four university hospitals, Department of Neurosurgery, are conducting tests.

In March of this year, it signed a mutual exclusive solution supply contract with Gynius, a Swedish colposcopy camera company for cervical cancer screening, and has resolved all 

overseas certification issues such as CFDA, CE, and FDA. In the case of the Chinese market, it signed an initial system export contract worth about 100,000 US dollars with Snet 

System Korea's Chinese subsidiary, mainly in Beijing.

In addition, AIDOT supplies its cervical cancer screening system, 'Cerviray A.I.', to Southeast Asia, and expects to raise exports of 4 million dollars (4 billion won) this year.

AIDOT plans to accelerate its overseas expansion by attracting foreign investment in earnest with this promising company selection as an opportunity. The goal is to create results 

that can immediately produce results not only in Korea but also abroad.

Jaehoon Jeong, CEO of AIDOT, said, "As an AI medical ICT company, AIDOT has been strengthening its own AI research institute's capabilities and discovering business models in the medical sector through cooperation with leading domestic medical staff. We will achieve significant results overseas by developing artificial intelligence-based medical solutions."

29th. Jun. 2020. 10:15 / JoongAng Ilbo Health Media / Reporter Jeong-ryeol Park park.jungryul@joongang.co.kr